PMC:7047369 / 8892-9783
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 115 | 209-214 | Species | denotes | human | Tax:9606 |
| 121 | 479-489 | Chemical | denotes | nucleoside | MESH:D009705 |
| 122 | 504-514 | Chemical | denotes | remdesivir | MESH:C000606551 |
| 123 | 516-525 | Chemical | denotes | ribavirin | MESH:D012254 |
| 124 | 558-577 | Chemical | denotes | lopinavir/ritonavir | MESH:C558899 |
| 125 | 647-658 | Chemical | denotes | chloroquine | MESH:D002738 |
LitCovid-PMC-OGER-BB
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T142 | 468-477 | CHEBI:35222;CHEBI:35222 | denotes | inhibitor |
| T141 | 479-489 | CHEBI:60783;CHEBI:60783 | denotes | nucleoside |
| T140 | 504-514 | DG_28 | denotes | remdesivir |
| T139 | 516-525 | DG_29 | denotes | ribavirin |
| T138 | 558-567 | DG_23;CHEBI:31781;CHEBI:31781 | denotes | lopinavir |
| T137 | 568-577 | DG_30 | denotes | ritonavir |
| T136 | 647-658 | CHEBI:3638;DG_10;CHEBI:3638 | denotes | chloroquine |
| T135 | 680-695 | CHEBI:50858;CHEBI:50858 | denotes | Corticosteroids |
| T134 | 730-736 | UBERON:0002405 | denotes | immune |
| T133 | 746-750 | UBERON:0002048 | denotes | lung |
| T132 | 872-878 | NCBITaxon:11118 | denotes | corona |
| T131 | 879-886 | NCBITaxon:10239 | denotes | viruses |
| T145 | 191-205 | BV_15 | denotes | immunogenicity |
| T144 | 209-214 | SP_6;NCBITaxon:9606 | denotes | human |
| T143 | 308-328 | CHEBI:52217;CHEBI:52217 | denotes | pharmaceutical agent |
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T7 | 460-467 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
| T8 | 663-678 | Body_part | denotes | immunoglobulins | http://purl.org/sig/ont/fma/fma62871 |
| T9 | 746-750 | Body_part | denotes | lung | http://purl.org/sig/ont/fma/fma7195 |
LitCovid-PD-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T6 | 746-750 | Body_part | denotes | lung | http://purl.obolibrary.org/obo/UBERON_0002048 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T56 | 144-145 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T57 | 209-214 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | human |
| T58 | 452-453 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T59 | 746-750 | http://purl.obolibrary.org/obo/UBERON_0002048 | denotes | lung |
| T60 | 746-750 | http://www.ebi.ac.uk/efo/EFO_0000934 | denotes | lung |
| T61 | 879-886 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | viruses |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T6 | 308-322 | Chemical | denotes | pharmaceutical | http://purl.obolibrary.org/obo/CHEBI_52217 |
| T7 | 427-437 | Chemical | denotes | antivirals | http://purl.obolibrary.org/obo/CHEBI_22587 |
| T8 | 460-467 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
| T9 | 468-477 | Chemical | denotes | inhibitor | http://purl.obolibrary.org/obo/CHEBI_35222 |
| T10 | 479-499 | Chemical | denotes | nucleoside analogues | http://purl.obolibrary.org/obo/CHEBI_60783 |
| T11 | 479-489 | Chemical | denotes | nucleoside | http://purl.obolibrary.org/obo/CHEBI_33838 |
| T12 | 504-514 | Chemical | denotes | remdesivir | http://purl.obolibrary.org/obo/CHEBI_145994 |
| T13 | 516-525 | Chemical | denotes | ribavirin | http://purl.obolibrary.org/obo/CHEBI_63580 |
| T14 | 530-549 | Chemical | denotes | protease inhibitors | http://purl.obolibrary.org/obo/CHEBI_37670|http://purl.obolibrary.org/obo/CHEBI_60258 |
| T16 | 539-549 | Chemical | denotes | inhibitors | http://purl.obolibrary.org/obo/CHEBI_35222 |
| T17 | 558-577 | Chemical | denotes | lopinavir/ritonavir | http://purl.obolibrary.org/obo/CHEBI_145924 |
| T18 | 558-567 | Chemical | denotes | lopinavir | http://purl.obolibrary.org/obo/CHEBI_31781 |
| T19 | 568-577 | Chemical | denotes | ritonavir | http://purl.obolibrary.org/obo/CHEBI_45409 |
| T20 | 635-645 | Chemical | denotes | interferon | http://purl.obolibrary.org/obo/CHEBI_52999 |
| T21 | 647-658 | Chemical | denotes | chloroquine | http://purl.obolibrary.org/obo/CHEBI_3638 |
| T22 | 872-878 | Chemical | denotes | corona | http://purl.obolibrary.org/obo/CHEBI_37409 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T64 | 0-68 | Sentence | denotes | What is in the pipeline for vaccine development and/or therapeutics? |
| T65 | 69-160 | Sentence | denotes | It appears that no vaccine will be available for at least one year, likely a little longer. |
| T66 | 161-254 | Sentence | denotes | Phase 1 trials for safety and immunogenicity in human populations are likely within 3 months. |
| T67 | 255-329 | Sentence | denotes | In terms of therapeutics there is no known effective pharmaceutical agent. |
| T68 | 330-402 | Sentence | denotes | There are over 200 registered clinical trials registered in China alone. |
| T69 | 403-578 | Sentence | denotes | Putative agents include antivirals; Griffithsin, a spike protein inhibitor, nucleoside analogues eg. remdesivir, ribavirin and protease inhibitors such as lopinavir/ritonavir. |
| T70 | 579-679 | Sentence | denotes | Immunomodulatory and other host targeted agents include interferon, chloroquine and immunoglobulins. |
| T71 | 680-792 | Sentence | denotes | Corticosteroids will potentially have benefit for immune mediated lung damage late in the course of disease [6]. |
| T72 | 793-891 | Sentence | denotes | Much of the theory stems from what we have learnt from limited trials in other corona viruses [7]. |